Osteopontin (OPN), a multifunctional phosphorylated glycoprotein, has emerged as a promising therapeutic candidate for ischemic stroke due to its established roles in a variety of physiological and pathological processes. This evidence concerns the gene SPP1 and ischemic stroke.